Results of Treatment of Venous Thromboembolic Complications in a Multidisciplinary Surgical Hospital of the Republic of Sakha (Yakutia)

• Published in: International Journal of Biomedicine
• Main Authors: Mikhail M. Vinokurov, Anton A. Yakovlev, Vasily P. Ignatiev, Natalia I. Douglas, Innokenty D. Ushnitsky, Gennady A. Palshin, Stepan S. Pavlov
• Format: Article in Journal/Newspaper
• Language: English
• Published: International Medical Research and Development Corporation 2019
• Subjects: deep vein thrombosis; venous thromboembolic complications; pulmonary embolism; activated partial thromboplastin time; Medicine; R; Sakha; Republic of Sakha; Yakutia
• Online Access: https://doi.org/10.21103/Article9(3)_ShC2; https://doaj.org/article/8b8edba9208c487480273a6f64a8ab6e

The article describes the main clinical risk factors for development of VTEC and the results of treatment in the Republic of Sakha (Yakutia) (RS(Y)). The main risk factors for VTEC development were oncological diseases in 75/25.5% patients (15 of them with newly diagnosed cancer and 60 patients on the background of chemotherapy) and trauma of the musculoskeletal system in 55/18.7% patients. In the structure of DVT of the lower limbs, an occlusion was most often (112/38.2% patients) found in the ileal-femoral segments. PE was detected in 21 (7.1%) patients. Personalized anticoagulant therapy based on the results of pharmacogenetic testing for a specific patient increases the effectiveness and safety of treatment. Catheter-directed thrombolytic therapy for massive and submassive PE is the preferred method in the absence of contraindications for surgical hospitals. In patients with ascending varicotrombosis, phlebectomy combined with excision of thrombosed tributaries speeds up recovery and reduces the time until discharge from the hospital.